Home / Private raises / Galvanize Therapeutics, Inc.

Galvanize Therapeutics, Inc.

Biotechnology · Redwood City, California · $136M sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-11-18D (new)$136M$136M26506(b)EquityNov 6SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Issuer

IndustryBiotechnology
LocatedRedwood City, California
EntityCorporation
IncorporatedDelaware
SEC CIK1659073

People named in the latest filing

NameRole
Doug GodshallExecutive Officer, Director
Seth HarrisonDirector
Antoine PapiernikDirector
Zack ScottDirector
David LewisDirector
Steve AnheierExecutive Officer
Isaac ZachariasDirector
Laura FrancisDirector
Garheng KongDirector

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?